Lead discovery and the concepts of complexity and lead-likeness in the evolution of drug candidates

Comprehensive Medicinal Chemistry II

Volumn 4, Issue , 2006, Pages 435-458

  Hann, M M ^a   Leach, A R ^a   Burrows, J N ^b   Griffen, E ^c  

^a GLAXOSMITHKLINE   (United Kingdom)

^b ASTRAZENECA R AND D   (Sweden)

^c ASTRAZENECA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 49949152506     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (54)

1. Goodfellow, P N. Chem. Br. 2002, 38, 3.
2. Horrobin, D. E. J. R. Soc. Med. 2000, 93, 341-345.
3. Lipinski, G. A.; Lombardo, E; Dominy, B. W; Feeney, R J. Adv. Drug Deliv. Rev. 1997, 23, 3-25.
4. Lipinski, G. A. J. Pharmacol. Toxicol Methods 2001, 44, 235-249.
5. Leo, A.; Hansch, C. Perspect. Drug Disc. Des. 1999, 11, 1-25.
6. Veber, D. E; Johnson, S. R.; Cheng, H.-Y; Smith, B. R.; Ward, K. W; Kopple, K. D. J. Med. Chem. 2002, 45, 2615-2623.
7. Clark, D. E.; Pickett, S. D. Drug Disc. Today 2000, 5, 49-58.
8. Oprea, T I.; Davis, A. M.; Teague, S. J.; Leeson, P D. J. Chem. Inf. Comp. Sei. 2001, 41, 1308-1315.
9. Rishton, G. M. Drug Disc. Today 2003, 8, 86-96.
10. Walters, W P.; Murcko, M. A. Methods Principles Med. Chem. 2000, 10, 15-32.
11. Leach, A. R.; Gillet, V J. An Introduction to Cheminformatics; Kluwer: Dordrecht, 2003.
12. Teague, S. J.; Davis, A. M.; Leeson, P D.; Oprea, T. Angew. Chem. Int. Ed. Engl. 1999, 38, 3743-3748.
13. Hann, M. M.; Leach, A. R.; Harper, G. J. Chem. Inf. Comp. Sei. 2001, 41, 856-864.
14. Sneader, W. Drug Prototypes and Their Exploitation; John Wiley and Sons Ltd.: New York, 1996.
15. Jacoby, E.; Schuffenhauer, A.; Popov, M.; Azzaoui, K.; Havill, B.; Schöpfer, U.; Engeloch, C.; Stanek, J.; Acklin, P.; Rigollier, R et al. Curr. Topics Med. Chem. 2005, 5, 397-411.
16. Oprea, T I. J. Comput.-Aided Mol. Des. 2000, 14, 251-264.
17. Ertl, P. J. Chem. Inf. Comp. Sei. 2003, 43, 374-380.
18. Hann, M. M.; Leach, A. R.; Green, D. V S. Computational Chemistry, Molecular Complexity and Screening Set Design. In Chemoinformatics in Drug Discovery; Oprea, T, Ed.; Wiley-VCH: New York, 2005.
19. Fink, T; Bruggesser, H.; Reymond, J.-L. Angew. Chem. Int. Ed. 2005, 44, 1504-1508.
20. Andrews, P R.; Graik, D. J.; Martin, J. L. J. Med. Chem. 1984, 21, 1648-1657.
21. Kuntz, I. D.; Chen, K.; Sharp, K. A.; Kollman, R A. Proc. Natl. Acad. Sei. USA 1999, 99, 9997-10002.
22. Hopkins, A. L.; Groom, G. R.; Alex, A. Drug Disc. Today 2004, 9, 430-431.
23. Burrows, J. N. High Concentration Screening: Integrated Lead Generation. Oral Presentation at the Society for Medicines Research: Trends in Drug Discovery, 2004.
24. Abad-Zapatero, G.; Metz, J. T. Drug Disc. Today 2005, 10, 464-469.
25. Deprez-Poulain, R.; Deprez, B. Curr. Top. Med. Chem. 2004, 4, 569-580.
26. Lipinski, C. A. Chemistry Quality and the Medicinal Chemistry-Biology Interface. Oral Presentation at the 6th Winter Conference on Medicinal and Bioorganic Chemistry, 2004.
27. Erlanson, D. A.; McDowell, R. S.; O'Brien, T. J. Med. Chem. 2004, 41, 3463-3482.
28. Carr, R.; Jhoti, H. Drug Disc. Today 2002, 7, 522-527.
29. Rees, D. G.; Congreve, M.; Murray, G. W; Carr, R. Nat. Rev. Drug Disc. 2004, 3, 660-672.
30. McGovern, S. L.; Helfand, B. T; Feng, B.; Shoichet, B. K. J. Med. Chem. 2003, 46, 4265-4272.
31. Rishton, G. M. Drug Disc. Today 1997, 2, 382-384.
32. Lesuisse, D.; Lange, G.; Deprez, P.; Bénard, D.; Schoot, B.; Delettre, G.; Marquette, J.-P; Broto, P.; Jean-Baptiste, V; Bichet, P. et al. J. Med. Chem. 2002, 45, 2379-2387.
33. Hajduk, P. J.; Sheppard, G.; Nettesheim, D. G.; Olejniczak, E. T; Shuker, S. B.; Meadows, R. P.; Steinman, D. H.; Carrera, G. M.; Marcotte, P A.; Severin, J. et al. J. Am. Chem. Soc. 1997, 119, 5818-5827.
34. Moy, E J.; Haraki, K.; Mobilio, D.; Walker, G.; Powers, R.; Tabei, K.; Tong, H.; Siegel, M. M. Anal. Chem. 2001, 73, 571-581.
35. Buck, E.; Wells, J. A. Proc. Natl. Acad. Sei. USA 2005, 102, 2719-2724.
36. Hann, M. M.; Green, R. Curr. Opin. Chem. Biol. 1999, 3, 379-383.
37. Congreve, M.; Garr, R.; Murray, G.; Jhoti, H. Drug Disc. Today 2003, 8, 876-877.
38. Maly, D. J.; Ghoong, I. G.; Ellman, J. A. Proc. Natl. Acad. Sei. USA 2000, 97, 2419-2424.
39. Bemis, G. W; Murcko, M. A. J. Med. Chem. 1996, 39, 2887-2893.
40. Bemis, G. W; Murcko, M. A. J. Med. Chem. 1999, 42, 5095-5099.
41. Leweil, X.-Q.; Judd, D. B.; Watson, S. P; Hann, M. M. J. Chem. Inf. Comp. Sei. 1998, 38, 511-522.
42. Leach, A. R.; Green, D. V S.; Hann, M. M.; Judd, D. B.; Good, A. G. J. Chem. Inf. Comp. Sei. 2000, 40, 1262-1269.
43. Hartshorn, M. J.; Murray, G. W; Gleasby, A.; Frederickson, M.; Tickle, I. J.; Jhoti, H. J. Med. Chem. 2004, 48, 403-413.
44. Baurin, N.; Aboul-Ela, E; Barril, X.; Davis, B.; Drysdale, M.; Dymock, B.; Finch, EI.; Fromonc, G.; Richardson, G.; Simmonice, El. ec al../. Chem. Inf. Comput. Sä. 2004, 44, 2157-2166.
45. Page, M. I.; Jencks, W. P. Proc. Natl. Acad. Set. USA 1971, 68, 1678-1683.
46. Murray, G. W; Verdonk, M. L. J. Comput.-Aided Mol. Des. 2002, 16, 741-753.
47. Schade, M.; Oschkinat, H. Curr. Opin. Drug Disc. Dev. 2005, 8, 365-373.
48. Boehm, H.-J.; Boehringer, M.; Bur, D.; Gmuended, H.; Huber, W; Klaus, W; Kostrewa, D.; Kuehne, H.; Luebbers, T.; Muenier-Keller, N. et al. J. Med. Chem. 2000, 43, 2664-2674.
49. Black, E.; Breed, J.; Breeze, A. L.; Embrey, Κ.; Garcia, R.; Gero, T W; Godfrey, L.; Kenny, P. W; Morley, A. D.; Minshull, G. A. et al. Bioorg. Med. Chem. Lett. 2005, 75, 2503-2507.
50. Shuker, S. B.; Hajduk, P. J.; Meadows, R. P.; Fesik, S. W. Science 1996, 214, 1531-1534.
51. Hue, I.; Lehn, J.-M. Proc. Natl. Acad. Sei. USA 1997, 94, 2106-2110.
52. Conti, E.; Rivetti, C.; Wonacott, A.; Brick, P. FEES Lett. 1998, 425, 229-233.
53. Davis, A. M.; Keeling, D. J.; Steele, J.; Tomkinson, N. P; Tinker, A. C. Curr. Top. Med. Chem. 2005, 5, 421-439.
54. Fattori, D. Drug Disc. Today 2004, 9, 229-238.